Loading organizations...
Ramius Capital Group delivers specialized alternative investment management solutions. The firm offers a diverse suite of investment products, encompassing multi-strategy hedge funds, managed futures, and bespoke fund of funds programs. With expertise in trading and execution, Ramius provides sophisticated financial instruments tailored for institutional and high-net-worth investors seeking nuanced market exposure.
Established in 1994 by co-founders Peter Cohen and Jeffrey Solomon, Ramius Capital Group focused on alternative asset management. Peter Cohen, a former Chairman and CEO of Shearson Lehman Brothers, brought substantial industry experience. Their combined expertise built a firm dedicated to identifying and leveraging complex investment opportunities.
Ramius serves a global clientele, offering tailored asset management strategies. Now operating as part of Cowen Investment Management LLC, the firm maintains its mission: to provide sophisticated investment vehicles. Its vision centers on generating strategic returns and managing risk for those pursuing non-traditional asset class investments.
Key people at Ramius Capital Group.
Key people at Ramius Capital Group.
Ramius Capital Group has 2 tracked investments across 2 companies. The latest tracked deal is $150.0M Series B in Latigo Biotherapeutics in March 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2025 | Latigo Biotherapeutics | $150.0M Series B | Ramius Capital Group | 5AM Ventures, Foresite Capital, Westlake Village BioPartners |
| Jul 1, 2012 | Bluebird Bio | $60.0M Series D | — | ARCH Venture Partners, Third Rock Ventures, Howie Furst, Forbion, RA Capital Management, Shire, TVM Capital |
